Figure 3
From: Survival benefit of surgery to patients with esophageal squamous cell carcinoma
Overall survivals in patients with esophageal SCC in subgroups of clinical stage and treatmentThe survival differences according to curative treatment modality in patients with T3N(+) and T4 (Surgery alone versus Surgery+Neo/adjuvant Tx versus definite CCRT) (a); and patients with stage T4N0-N(+) (Surgery+Neo/adjuvant Tx versus definite CCRT) (b). Additionally, Kaplan-Meier survival curves for patients with stage T2-T4 in the surgery group according to achieving pathologic complete response or not (c), and in the CCRT group according to the dose of radiotherapy (d).
